(A) Based on the most reliable and up-to-date scientific evidence and guidance from the U.S. Surgeon General, the City Council finds that the rapid introduction of legalized edible and consumable nonedible products containing any amount of cannabinoids ("cannabinoid product"), including tetrahydrocannabinol ("THC"), presents a significant potential threat to the public health, safety, and welfare of the residents of the city, and can interfere with brain development in youth and adolescents.
(B) Minnesota has recognized the danger cannabinoid products pose to youth and adolescents by prohibiting the sale of cannabinoid products to those under age 21 and regulating label design. (M.S. § 151.72, subds. 3(c) and 5a(b)). As such, the City Council desires to prevent the sale of cannabinoid products to underage people within the city.
(C) The City Council finds that in this emerging marketplace there is a real likelihood that people may purchase mislabeled cannabinoid products. These noncompliant products represent a unique risk to the general welfare of the community.
(D) The City Council finds that a local regulatory system for cannabinoid product sellers is appropriate and not unduly burdensome to ensure that sellers comply with the state cannabis laws and business standards of the city to protect the health, safety, and welfare of the city's youth and all residents. The city does not intend to inhibit the production, sale, or use of medical cannabis products.
(Ord. 307, passed 7-11-2023)